Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Stefano FerrariGaetano Bacci

Abstract

We compared two chemotherapy regimens that included methotrexate (MTX), cisplatin (CDP), and doxorubicin (ADM) with or without ifosfamide (IFO) in patients with nonmetastatic osteosarcoma of the extremity. Patients age ≤ 40 years randomly received regimens with the same cumulative doses of drugs (ADM 420 mg/m(2), MTX 120 g/m(2), CDP 600 mg/m(2), and IFO 30 g/m(2)) but with different durations (arm A, 44 weeks; arm B, 34 weeks). IFO was given postoperatively when pathologic response to MTX-CDP-ADM was poor (arm A) or given in the primary phase of chemotherapy with MTX-CDP-ADM (arm B). End points of the study included pathologic response to preoperative chemotherapy, toxicity, and survival. Given the feasibility of accrual, the statistical plan only permitted detection of a 15% difference in 5-year overall survival (OS). From April 2001 to December 2006, 246 patients were enrolled. Two hundred thirty patients (94%) underwent limb salvage surgery (arm A, 92%; arm B, 96%; P = .5). Chemotherapy-induced necrosis was good in 45% of patients (48% in arm A, 42% in arm B; P = .3). Four patients died of treatment-related toxicity (arm A, n = 1; arm B, n = 3). A significantly higher incidence of hematologic toxicity was reported in arm B. ...Continue Reading

Associated Clinical Trials

References

Dec 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I J LewisA W Craft
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan S BielackKurt Winkler
Jun 5, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E I HaubenP C W Hogendoorn
May 20, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S SmelandG Saeter
Jul 22, 2004·The Oncologist·Neyssa MarinaRichard Gorlick
Oct 26, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefano FerrariUNKNOWN Italian and Scandinavian Sarcoma Groups
Feb 3, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marie-Cécile Le DeleyUNKNOWN Société Française d'Oncologie Pédiatrique (SFOP)
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul A MeyersUNKNOWN Children's Oncology Group
Mar 10, 2010·Cancer Treatment and Research·N MarinaM Bernstein
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P C W HogendoornD Vanel

❮ Previous
Next ❯

Citations

Aug 3, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A RedondoUNKNOWN SEOM
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G BacciM DePaolis
Feb 13, 2001·The International Journal of Biochemistry & Cell Biology·K Trieb, R Kotz
Oct 26, 2013·Journal of Translational Medicine·Stefano FerrariStefano Fais
Jul 16, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M HongP D Stalley
Apr 1, 2014·Journal of Cancer Research and Clinical Oncology·Jian ChenZheng-dong Cai
Oct 30, 2015·Expert Opinion on Pharmacotherapy·Stefano Ferrari, Massimo Serra
Oct 27, 2015·Pediatric Blood & Cancer·Rajkumar VenkatramaniMurali Chintagumpala
Jan 10, 2013·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Matilda DhimaThomas J Salinas
Sep 28, 2015·The Orthopedic Clinics of North America·Jared L HarwoodThomas J Scharschmidt
Apr 5, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Wenyan LeongDong-An Wang
Mar 22, 2016·Expert Review of Anticancer Therapy·Cristina Meazza, Paolo Scanagatta
Sep 15, 2015·Cancer Chemotherapy and Pharmacology·Vered Shkalim-ZemerIan J Cohen
Mar 19, 2014·Current Opinion in Pharmacology·Sander M BotterBruno Fuchs
Oct 30, 2014·Clinical Orthopaedics and Related Research·Luis Aponte-TinaoGermán L Farfalli
Mar 26, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·S DuchiG Varchi
Jun 29, 2016·European Journal of Cancer Care·H HaoL Hao
Jul 30, 2016·Journal of Cancer Research and Clinical Oncology·Andrea AngeliniPietro Ruggieri
Aug 18, 2005·Journal of Vascular and Interventional Radiology : JVIR·John W CullenCynthia M Kelly
Oct 21, 2016·Rheumatology and Therapy·Ryan A DurfeeHue H Luu
Nov 23, 2006·International Journal of Radiation Oncology, Biology, Physics·Gaetano BacciPiero Picci
May 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert G Maki
Nov 26, 2016·Prosthetics and Orthotics International·Mattia Morri, Cristiana Forni
May 22, 2018·Current Opinion in Oncology·Sandra J Strauss, Jeremy S Whelan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.